Short Interest in GlucoTrack, Inc. (NASDAQ:GCTK) Increases By 579.9%

GlucoTrack, Inc. (NASDAQ:GCTKGet Free Report) was the recipient of a significant increase in short interest in November. As of November 15th, there was short interest totalling 257,700 shares, an increase of 579.9% from the October 31st total of 37,900 shares. Approximately 8.3% of the shares of the stock are short sold. Based on an average daily trading volume, of 319,100 shares, the days-to-cover ratio is presently 0.8 days.

GlucoTrack Price Performance

GCTK stock traded down $0.01 during midday trading on Friday, hitting $0.24. 154,087 shares of the stock were exchanged, compared to its average volume of 112,859. The stock’s 50-day moving average price is $1.59 and its 200-day moving average price is $1.92. The stock has a market cap of $1.40 million, a price-to-earnings ratio of -0.09 and a beta of 0.16. GlucoTrack has a fifty-two week low of $0.22 and a fifty-two week high of $4.95. The company has a debt-to-equity ratio of 0.52, a quick ratio of 0.14 and a current ratio of 0.14.

About GlucoTrack

(Get Free Report)

GlucoTrack, Inc, a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States. It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain.

Featured Articles

Receive News & Ratings for GlucoTrack Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GlucoTrack and related companies with MarketBeat.com's FREE daily email newsletter.